Application Notes & Case Studies

  1. Streamlining Patient Recruitment With AI–Driven Site Identification 5/1/2025

    This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.

  2. EHR-To-EDC Success In A Complex, Adaptive Platform Trial 4/17/2025

    I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

  3. Unlocking Recruitment Potential In Trial-Naïve Sites 4/17/2025

    Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

  4. Delivering Specialist Neurology Support 4/17/2025

    Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

  5. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

  6. Accelerating Early Phase Oncology Study Development 4/17/2025

    Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.

  7. Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study 4/17/2025

    This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

  8. Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer 4/16/2025

    This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.

  9. Pioneering The End-To-End Decentralized Trial Experience 4/16/2025

    This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.

  10. Accelerate Your Oncology Breakthroughs 4/16/2025

    Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.